ex. 4). in 2016, mylan filed an abbreviated new drug application (anda) with the fda, seeking...

7

Upload: others

Post on 06-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 2: Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 3: Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 4: Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 5: Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 6: Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on
Page 7: Ex. 4). In 2016, Mylan filed an Abbreviated New Drug Application (ANDA) with the FDA, seeking approval of a generic colchicine product. (DI. 92, Meckstroth Decl., 116). Based on